Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-18-001799

Chief Financial Officer sold 32,400 shares at an average $7.30 ($236,400)

  • Chief Financial Officer acquired 32,400 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BLOCH KATHLEEN P. Chief Financial Officer 2018-01-08 Option exercise +20,000 $2.90 $58,000 248,638 D: show line 1 in the form
BLOCH KATHLEEN P. Chief Financial Officer 2018-01-08 Option exercise +12,400 $4.69 $58,156 261,038 D: show line 2 in the form
BLOCH KATHLEEN P. Chief Financial Officer 2018-01-08 Sale −10,000 $7.15 $71,500 251,038 D: show line 3 in the form
BLOCH KATHLEEN P. Chief Financial Officer 2018-01-08 Sale −12,400 $7.25 $89,900 238,638 D: show line 4 in the form
BLOCH KATHLEEN P. Chief Financial Officer 2018-01-08 Sale −10,000 $7.50 $75,000 228,638 D: show line 5 in the form
Open-market sales · 32,400 sh · avg $7.30 · $236,400

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
BLOCH KATHLEEN P. Chief Financial Officer 2018-01-08 Option exercise · Stock Option (Right to Buy) −20,000 20,000 D: show line 6 in the form
BLOCH KATHLEEN P. Chief Financial Officer 2018-01-08 Option exercise · Stock Option (Right to Buy) −12,400 49,600 D: show line 7 in the form
Loading xslF345X03/tv483029_4.xml…